Investigational Diabetes Drugs Make Cancer Cells More Vulnerable to Chemotherapy

News   Jan 03, 2018 | Original story from the Dana-Farber Cancer Institute

 
Investigational Diabetes Drugs Make Cancer Cells More Vulnerable to Chemotherapy
 
 
 

RELATED ARTICLES

Boyds Acquires New Cambridge Office to Support Rapid Growth

News

Boyds, the drug development consultancy which helps pharmaceutical companies translate great science into marketable medicines for patient benefit, has relocated into new premises in Cambridge.

READ MORE

Protein That Helps Keep Breast Cancer Dormant Identified

News

A protein kinase that stops breast cancer cells growing and spreading has been outlined in new research.

READ MORE

Combination Chemotherapy Could Significantly Improve Deadly Brain Tumor Treatment

News

A team led by Massachusetts General Hospital (MGH) investigators has found that adding the chemotherapy drug hydroxyurea to the current chemotherapy protocol for glioblastoma significantly increased survival in animal models.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE